Woodcock Barry G
Dustri Medical Science Publications, Munich-Oberhaching, Germany.
Int J Clin Pharmacol Ther. 2017 Mar;55(3):201-200. doi: 10.5414/cp202971.
The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses employed, 3. Drug molecules involved, 4. Dosages applied, 5. Data collected, 6. Discussion of the findings, 7. Deductions made, and 8. Documentation are in accord with the objectives of the study and meet the requirements of evidence-based medicine. This tool, although easy to apply, requires a high level of clinical pharmacology expertise, especially in the fields of drug disposition, pharmacokinetics, and drug action.
使用8-D评估有助于临床药理学杂志的编辑全面了解提交稿件的同行评审过程。8-D评估包括同行评审标准,以确定:1. 研究设计,2. 采用的诊断方法,3. 涉及的药物分子,4. 应用的剂量,5. 收集的数据,6. 研究结果的讨论,7. 得出的推论,以及8. 文件记录是否符合研究目标并满足循证医学的要求。该工具虽然易于应用,但需要高水平的临床药理学专业知识,尤其是在药物处置、药代动力学和药物作用领域。